General Information of the Compound
Compound ID
CP0440957
Compound Name
5-ethyl-2-(2-pyrrolidin-1-ylethyl)pyridine
    Show/Hide
Synonyms
5-ethyl-2-(2-(pyrrolidin-1-yl)ethyl)pyridine
CHEMBL271300
SCHEMBL13990825
ZINC29131629
    Show/Hide
Structure
Formula
C13H20N2
Molecular Weight
204.317
Canonical SMILES
CCc1ccc(CCN2CCCC2)nc1
    Show/Hide
InChI
InChI=1S/C13H20N2/c1-2-12-5-6-13(14-11-12)7-10-15-8-3-4-9-15/h5-6,11H,2-4,7-10H2,1H3
    Show/Hide
InChIKey
LTRFAPGENZNRNS-UHFFFAOYSA-N
Physicochemical Property
logP
2.2823
Rotatable Bonds
4
Heavy Atom Count
15
Polar Areas
16.13
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
15

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44456496
ChEMBL ID
CHEMBL271300
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 230 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 5-ethyl-2-(2-(pyrrolidin-1-yl)ethyl)pyridine )
Drug Name 5-ethyl-2-(2-(pyrrolidin-1-yl)ethyl)pyridine
Target(s)
Histamine H3 receptor (H3R)
Inhibitor